|
|
| | Sulfamic acid, [[2,4,6-tris(1-methylethyl)phenyl]acetyl]-, 4-[(2-amino-2-methyl-1-oxopropyl)amino]-2,6-bis(1-methylethyl)phenyl ester (9CI) Basic information |
| Product Name: | Sulfamic acid, [[2,4,6-tris(1-methylethyl)phenyl]acetyl]-, 4-[(2-amino-2-methyl-1-oxopropyl)amino]-2,6-bis(1-methylethyl)phenyl ester (9CI) | | Synonyms: | Sulfamic acid, [[2,4,6-tris(1-methylethyl)phenyl]acetyl]-, 4-[(2-amino-2-methyl-1-oxopropyl)amino]-2,6-bis(1-methylethyl)phenyl ester (9CI);ACAT-IN-9 | | CAS: | 199984-40-2 | | MF: | C33H51N3O5S | | MW: | 601.84 | | EINECS: | | | Product Categories: | | | Mol File: | 199984-40-2.mol | ![Sulfamic acid, [[2,4,6-tris(1-methylethyl)phenyl]acetyl]-, 4-[(2-amino-2-methyl-1-oxopropyl)amino]-2,6-bis(1-methylethyl)phenyl ester (9CI) Structure](CAS/20210305/GIF/199984-40-2.gif) |
| | Sulfamic acid, [[2,4,6-tris(1-methylethyl)phenyl]acetyl]-, 4-[(2-amino-2-methyl-1-oxopropyl)amino]-2,6-bis(1-methylethyl)phenyl ester (9CI) Chemical Properties |
| density | 1.119±0.06 g/cm3(Predicted) | | pka | 1.84±0.70(Predicted) |
| | Sulfamic acid, [[2,4,6-tris(1-methylethyl)phenyl]acetyl]-, 4-[(2-amino-2-methyl-1-oxopropyl)amino]-2,6-bis(1-methylethyl)phenyl ester (9CI) Usage And Synthesis |
| Uses | ACAT-IN-9 is an acyl-Coenzyme A:cholesterol acyltransferase (ACAT) inhibitor extracted from patent EP1236468A1, example 207. ACAT-IN-9 inhibits NF-κB mediated transcription[1]. | | References | [1] Joseph Anthony Cornicelli, et al. Sulfonylaminocarbonyl derivatives for the treatment of nuclear factor-kappa B mediated diseases and disorders. EP1236468A1. |
| | Sulfamic acid, [[2,4,6-tris(1-methylethyl)phenyl]acetyl]-, 4-[(2-amino-2-methyl-1-oxopropyl)amino]-2,6-bis(1-methylethyl)phenyl ester (9CI) Preparation Products And Raw materials |
|